Fluorescent graphene quantum dots as traceable, pH-sensitive drug delivery systems

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 6709-6724

  Qiu, Jichuan ^a   Zhang, Ruibin ^b   Li, Jianhua ^a   Sang, Yuanhua ^a   Tang, Wei ^c   Gil, Pilar Rivera ^d   Liu, Hong ^a,e  

^a SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Controlled release; Drug delivery; Graphene quantum dots; pH sensitive; Traceable

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; DOXORUBICIN; GRAPHENE QUANTUM DOT; QUANTUM DOT; UNCLASSIFIED DRUG; ARGINYL-GLYCYL-ASPARTIC ACID; DRUG CARRIER; GRAPHITE; OLIGOPEPTIDE;

ACIDIFICATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL VACUOLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; FEASIBILITY STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; NANOFABRICATION; PROSTATE CANCER CELL LINE; SYNTHESIS; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; KINETICS; LIGHT RELATED PHENOMENA; MOUSE; PH; PROCEDURES;

ANIMALS; CELL LINE; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FLUORESCENCE; GRAPHITE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MICE; OLIGOPEPTIDES; OPTICAL PHENOMENA; QUANTUM DOTS;

EID: 84945951655     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S91864     Document Type: Article

References (45)

1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
2. Du JZ, Du XJ, Mao CQ, Wang J. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc. 2011;133(44):17560-17563.
3. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16-20.
4. Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine. 2011;6:765-774.
5. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133-149.
6. Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev. 2014;43(3):744-764.
7. Zrazhevskiy P, Sena M, Gao XH. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev. 2010;39(11):4326-4354.
8. Lu YJ, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2012;64:342-352.
9. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56(11):1649-1659.
10. Zhao D, Zhao X, Zu Y, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine. 2010;5:669-677.
11. Rivera Gil P, Vazquez Vazquez C, Giannini V, et al. Plasmonic nanoprobes for real-time optical monitoring of nitric oxide inside living cells. Angew Chem. 2013;125(51):13939-13943.
12. Schweiger C, Hartmann R, Zhang F, Parak WJ, Kissel TH, Rivera Gil P. Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite charge. J Nanobiotechnology. 2012;10:28.
13. Rivera Gil P, Nazarenus M, Ashraf S, Parak WJ. pH-Sensitive capsules as intracellular optical reporters for monitoring lysosomal pH changes upon stimulation. Small. 2012;8(6):943-948.
14. Lee ES, Gao Z, Bae YH. Recent progress in tumor pH targeting nanotechnology. J Control Release. 2008;132(3):164-170.
15. Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008;126(3):187-204.
16. Wu H, Zhu L, Torchilin VP. pH-Sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials. 2013;34(4):1213-1222.
17. Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev. 2012;64:327-341.
18. Zhang H, Wang C, Chen B, Wang X. Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery system. Int J Nanomedicine. 2012;7:235-242.
19. Ashwanikumar N, Kumar NA, Nair SA, Kumar GV. Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon. Int J Nanomedicine. 2012;7:5769-5779.
20. Gu Y-J, Cheng J, Jin J, Cheng SH, Wong W-T. Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells. Int J Nanomedicine. 2011;6:2889-2898.
21. Basuki JS, Duong HTT, Macmillan A, et al. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano. 2013;7(11):10175-10189.
22. Jana A, Devi KSP, Maiti TK, Singh NDP. Perylene-3-ylmethanol: fluorescent organic nanoparticles as a single-component photoresponsive nanocarrier with real-time monitoring of anticancer drug release. J Am Chem Soc. 2012;134(18):7656-7659.
23. Probst CE, Zrazhevskiy P, Bagalkot V, Gao XH. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev. 2013;65(5):703-718.
24. Zhu YW, Murali S, Cai WW, et al. Graphene and graphene oxide: synthesis, properties, and applications. Adv Mater. 2010;22(35):3906-3924.
25. Babu SS, Mohwald H, Nakanishi T. Recent progress in morphology control of supramolecular fullerene assemblies and its applications. Chem Soc Rev. 2010;39(11):4021-4035.
26. Saito N, Usui Y, Aoki K, et al. Carbon nanotubes: biomaterial applications. Chem Soc Rev. 2009;38(7):1897-1903.
27. Geim AK, Novoselov KS. The rise of graphene. Nat Mat. 2007;6(3):183-191.
28. Yang WR, Ratinac KR, Ringer SP, Thordarson P, Gooding JJ, Braet F. Carbon nanomaterials in biosensors: should you use nanotubes or graphene? Angew Chem Int Ed Engl. 2010;49(12):2114-2138.
29. Liu ZA, Sun XM, Nakayama-Ratchford N, Dai HJ. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 2007;1(1):50-56. [Erratum in ACS Nano. 2010;4(12):7726].
30. Bhirde AA, Patel V, Gavard J, et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano. 2009;3(2):307-316.
31. Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine. 2011;6:2963-2979.
32. Yang XY, Wang YS, Huang X, et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem. 2011;21(10):3448-3454.
33. Zhang LM, Xia JG, Zhao QH, Liu LW, Zhang ZJ. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010;6(4):537-544.
34. Sun XM, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008;1(3):203-212.
35. Liu Z, Robinson JT, Sun XM, Dai HJ. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 2008;130(33):10876-10877.
36. Shen J, Zhu Y, Yang X, Li C. Graphene quantum dots: emergent nanolights for bioimaging, sensors, catalysis and photovoltaic devices. Chem Commun. 2012;48(31):3686-3699.
37. Zhu SJ, Zhang JH, Qiao CY, et al. Strongly green-photoluminescent graphene quantum dots for bioimaging applications. Chem Commun. 2011;47(24):6858-6860.
38. Danhier F, Breton AL, Préat Vr. RGD-based strategies to target alpha (v) beta (3) integrin in cancer therapy and diagnosis. Mol Pharm. 2012;9(11):2961-2973.
39. Liu Z, Sun XM, Nakayama-Ratchford N, Dai HJ. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 2007;1(1):50-56.
40. Depan D, Shah J, Misra RDK. Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response. Mat Sci Eng C-Mater. 2011;31(7):1305-1312.
41. Yang XQ, Grailer JJ, Rowland IJ, et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano. 2010;4(11):6805-6817.
42. Yang XY, Zhang XY, Liu ZF, Ma YF, Huang Y, Chen Y. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C. 2008;112(45):17554-17558.
43. Qiu J, Li J, Wang G, et al. In vitro Investigation on the biodegradability and biocompatibility of genipin cross-linked porcine acellular dermal matrix with intrinsic fluorescence. ACS Appl Mater Interfaces. 2012;5(2):344-350.
44. Davis ME, Shin DM, Chen ZG. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771-782.
45. Zhao Z, Huang D, Yin Z, Chi X, Wang X, Gao J. Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: magnetic control and pH-responsive release. J Mater Chem. 2012;22(31):15717-15725.